Literature DB >> 6109309

Transglutaminase and epsilon-(gamma-glutamyl) lysine isopeptide bonds in eukaryotic cells.

P J Birckbichler, M K Patterson.   

Abstract

Transglutaminase activity was reduced in malignant hepatoma, virus-transformed human and hamster cells, and chemically transformed mouse cells when compared to normal counterparts. The reduction in enzyme activity reflected the presence of fewer transglutaminase molecules in transformed cells. Greater amounts of the enzyme activity were particulate-associated in confluent and arrested normal human cells. Indirect immunofluorescence studies with antibody to cellular transglutaminase demonstrated the presence of transglutaminase in Triton X-100-insoluble material. A parallel between pericellular fibronectin and transglutaminase (TGase) was demonstrated. Normal human and mouse cells that elicited contact inhibition of growth and had the high TGase activity also had more epsilon-(gamma-glutamyl) lysine isopeptide bonds than transformed counterparts. Similarly nonproliferating human cells had higher transglutaminase activity and isopeptide levels than did proliferating populations. These results suggest that isopeptide bond formation stabilizes the cell membrane and contributes to a nonproliferating state. Inhibition of isopeptide formation should therefore lead to a mitogenic response. Preliminary results support such a relationship. A model depicting control of isopeptide formation at either enzyme or substrate level is presented.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6109309

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  6 in total

1.  Changes in transglutaminase activity in carbon tetrachloride-damaged rat liver.

Authors:  H Kohno; K Kashimura; S Katoh; Y Ohkubo
Journal:  Experientia       Date:  1991-01-15

2.  On the Structural Role of the epsilon-(gamma-Glutamyl)lysine Cross-link in the Cell Membrane.

Authors:  R B Haugland; T I Lin; R M Dowben; P J Birckbichler
Journal:  Biophys J       Date:  1982-01       Impact factor: 4.033

3.  Transglutaminase in cell proliferation and transformation.

Authors:  S Metafora; G Peluso; G Ravagnan; M Marchese; M Di Pietro; A Mancini; N Panza; A Fusco; R Porta
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

4.  Cellular transglutaminase has affinity for extracellular matrix.

Authors:  H F Upchurch; E Conway; M K Patterson; P J Birckbichler; M D Maxwell
Journal:  In Vitro Cell Dev Biol       Date:  1987-11

5.  Increase in proliferative markers after inhibition of transglutaminase.

Authors:  P J Birckbichler; G R Orr; M K Patterson; E Conway; H A Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

6.  Microbial transglutaminase nanoflowers as an alternative nanomedicine for breast cancer theranostics.

Authors:  Syeda Warisul Fatima; Khalid Imtiyaz; Mohammad M Alam Rizvi; Sunil K Khare
Journal:  RSC Adv       Date:  2021-10-26       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.